Transposagen Biopharmaceuticals, Inc. — Form D
Transposagen Biopharmaceuticals, Inc. of LEXINGTON, KY, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-20. The offering totals $1.0M, of which $725K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-12-20
- Form: D
- Accession: 0000911959-11-000027
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $725K
- Remaining: $275K
- Minimum investment: $25K
- Investors: 7
- Date of first sale: 2011-12-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-170391
Issuer
- Name: Transposagen Biopharmaceuticals, Inc.
- CIK: 0001537601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 145 GRAHAM AVENUE, LEXINGTON, KY, 40506
- Phone: 859-428-8561
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Eric M Ostertag | Director | Lexington, KY |
| Eric M Ostertag | Executive Officer | Lexington, KY |
| Joseph M Ruiz | Executive Officer | Lexington, KY |
| Eric M. Ostertag | Director | Lexington, KY |
| Eric M. Ostertag | Executive Officer | Lexington, KY |
| Joseph M. Ruiz | Executive Officer | Lexington, KY |
Other filings by this issuer (1)
More